Jorge Gustavo Azpiroz
Jorge Gustavo Azpiroz Filho is a psychiatrist, graduated in Medicine from the Universidade de Caxias do Sul (2012), and in Psychiatry from the Pontifícia Universidade Católica do Rio Grande do Sul (2016). He has a master’s degree in Psychiatry and behavioral sciences from Universidade Federal do Rio Grande do Sul (2019). Also has training in cognitive behavioral therapy from the same institution (2016) and training in schema therapy from Wainer and NJ/NYC ISST. He acted as supervisor of the medical residency in psychiatry at Hospital Sao Lucas da PUCRS from 2018 to 2021, in the specialized Anxiety outpatient clinic, an area with which he has worked in the private practice for the last 7 years. He currently works in his private practice and is a guest professor of CBT specialization courses.
Schema Therapy and the Transdiagnostic Model
Co-Presented with Leonardo Wainer & André Kolb
The upcoming symposium is poised to be an exploration into the integration of the transdiagnostic model with Schema Therapy. This event seeks to unravel the complexities of addressing common underlying factors that transcend traditional diagnostic boundaries, offering a fresh perspective on therapeutic interventions for individuals with personality disorders. The symposium will delve into the core principles of Schema Therapy, examining how this modality can effectively address transdiagnostic features present in diverse personality disorders. The presentation will showcase empirical evidence and a teorethical framework of ST and the Transdiagnostic Model. Attendees can expect to gain insights into tailoring interventions that go beyond conventional diagnostic categories, providing a more comprehensive and nuanced approach to treatment. The presenters will discuss the practical implications of transdiagnostic schema work, emphasizing the importance of identifying and modifying maladaptive schemas that cut across different personality disorder presentations. The symposium will offer attendees hands-on experience in applying transdiagnostic principles within the framework of Schema Therapy, fostering a deeper understanding of the therapeutic process. Furthermore, the symposium will encourage a collaborative dialogue among professionals, exploring the challenges and opportunities in transdiagnostic schema-focused work. Discussions will center around adapting traditional therapeutic approaches to better suit the unique needs of individuals with personality disorders, transcending the limitations imposed by strict diagnostic categories. This symposium aims to present a different view on conceptualization and treatment of clients within the ST model. Attendees can anticipate gaining valuable insights and practical tools to enhance their clinical practices, fostering a more integrative and nuanced approach to working with individuals who present with complex and overlapping diagnostic features within the context of Schema Therapy.
Personality disorders prescribing guide: how to address to comorbidities of our patients
Personality disorders (PDs) have a prevalence in the general population of 7,8%, and clearly present one of the most important indications for schema therapy. However, like most mental disorders, the presence of comorbid diagnoses is common, with each of the PDs more frequently presenting certain profiles of associated diagnoses. Being clear about which psychopathologies to seek to identify, in addition to assisting in the most appropriate psychotherapeutic management, is also essential to know how to differentiate when the patient needs referral for evaluation of the use of psychotropic drugs and when the patient is only presenting maladaptive coping strategies. Through a review of the literature, using the DSM-5TR to identify main comorbidities, this presentation aims to present tools to help the management of PDs patients through updated guidelines, and search for recent articles on pharmacological management of serious situations in PDs cases.